ELISA – News and Features
Article
How Broadly Neutralizing Antibodies Are Driving Next-Gen Vaccines
This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the prevention of HIV, but also for other rapidly mutating viruses such as influenza and SARS-CoV-2.
News
Our Perception of Body Weight Differs From How We Perceive Object Weight
Researchers found that body parts like hands defy the size-weight illusion that applies to objects. In a study, participants perceived larger hands as heavier and smaller hands as lighter, contrary to how objects are perceived.
News
Intermittent Fasting Shows Benefits for Weight Loss and Glucose Regulation
A study by UGR and UPNA highlights early fasting (5 p.m.–9 a.m.) as a safe, effective method for weight loss and improved glucose regulation. Early fasting reduced subcutaneous abdominal fat and improved overnight glucose levels.
News
Detection Tool Fast-Tracks Measurements of Protein Interactions
The SIMPL2 platform, developed by University of Toronto researchers, simplifies and improves protein interaction measurement, crucial for understanding disease mechanisms and developing drug therapies.
Article
New Purification Techniques in Biopharmaceuticals
This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, monoclonal antibody therapies and gene therapies.
News
Graphene Stacking Discovery Could Herald New Era for Quantum Tech
Researchers have uncovered a new phenomenon in graphene research, observing growth-induced self-organized graphene stacking domains that could kick-start the development of advanced quantum technologies.
News
Researchers Engineer Synthetic Genes That Mimic How Cells Build Tissues
Researchers have developed synthetic genes that function like the genes in living cells, offering a path toward using a suite of simple building blocks that can be programmed to make complex biomolecular materials.
News
Low-Cost Device Detects Prostate and Colorectal Cancer in an Hour
A team at The University of Texas at El Paso has developed a microfluidic device that can quickly and affordably detect colorectal and prostate cancer. This innovative biochip eliminates the need for expensive equipment.
Industry Insight
The Next Big Thing in Genomics? Proteomics.
In this article, explore how next-generation protein sequencing is helping to unlock the proteome.
News
Could We Make KRAS Inhibitors More Effective Against Pancreatic Cancer?
KRAS inhibitors are showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Now, researchers have discovered a new mechanism of resistance that suggests an opportunity to make the treatment more effective.
Advertisement